Polymeric micelle drug carriers for tumor targeting

ACS Symposium Series

Volumn 923, Issue , 2006, Pages 27-39

  Yokoyama, Masayuki ^a  

^a KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36949006298     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-2006-0923.ch003     Document Type: Conference Paper

References (45)

1. Yokoyama M. and Okano T. Targetable drug carriers: Present status and a future perspective. Advanced Drug Delivery Reviews 1996, 21, 77-80.
2. Sugiyama Y. Importance of pharmacokinetic considerations in the development of drug delivery systems. Adv Drug Delivery Reviews 1996, 19, 333-334.
3. Matsumura Y. and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986, 46, 6387-6392.
4. Maeda H., Seymour L.-W., and Miyamoto Y. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconjugate Chem 1992, 3, 351-361.
5. Litzinger D.C., Buiting A.-M.-J., van Rooijen N., and Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1994, 1190, 99-107.
6. Illum L., Davis S.S., Miller R.-H., Mak E., and West P. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer - Poloxamine 908. Life Sci. 1987, 40, 367-374.
7. Tuzar Z. and Kratochvil P. Block and graft copolymer micelles in solution. Advances in Colloid and Interface Science 1976, 6, 201-232.
8. Yokoyama M., Inoue S., Kataoka K., Yui N., Okano T., and Sakurai Y. Molecular design for missile drug: Synthesis of adriamycin conjugated with IgG using poly(ethylene glycol)-poly(aspartic acid) block copolymer as intermediate carrier. Die Makromolekulare Chemie 1989, 190, 2041-2054.
9. Kabanov A.V., Chekhonin V.P., Alakhov V.Y., Batrakova E.V., Lebedev A.S., Melik-Nubarov N.S., Arzhakov S.A., Levashov A.V., Morozov G.V., Severin E.S., and Kabanov V.A. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: Micelles as microcontainers for drug targeting. FEBS Lett. 1989, 258, 343-345.
10. Yokoyama M., Fukushima S., Uehara R., Okamoto K., Kataoka K., Sakurai Y., and Okano T. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid rumor. J Controlled Release 1998, 50, 79-92.
11. Yokoyama M., Satoh A., Sakurai Y., Okano T., Matsumura Y., Kakizoe T., and Kataoka K. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Controlled Release 1998, 55, 219-229.
12. Li Y. and Kwon G.S. Methotrexate esters of polyethylene oxide)-blockpoly(2-hydroxyethyl-L-aspartamide). Part 1: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm. Res. 2000, 17, 607-611.
13. Lavasanifar A., Samuel J., and Kwon G.S. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles compoased of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide). J Controlled Release 2002, 79, 165-172.
14. Allen C., Han J., Yu Y., Maysinger D., and Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Controlled Release 2000, 51, 275-286.
15. Trubetskoy V.S. and Torchilin V.P. Polyethyleneglycol based micelles as carriers of the therapeutic and diagnostic agents. S.T.P. Parma Science 1996, 6, 79-86.
16. Zhang X., Burt H. M., Von Hoff D., Dexter D., Mangold G., Degen D., Oktaba A. M., and Hunter W. L. An investigation of the antitumor activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemother. Pharmacol. 1997, 40, 81-86.
17. Rolland A., O'Mullane J., Goddard P., Brookman L., and Petrak K. New macromolecular carriers for drugs. I. Preparation and characterization of poly(oxyethylene-b-isoprene-b-oxyethylene) block copolymer aggregates. J Appl. Polym. Sci. 1992, 1195-1203.
18. Inoue T., Chen G., Nakamae K., and Hoffman A.S. An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. J Controlled Release 1998, 55, 221-229.
19. Rapoport N.Y., Herron J.N., Pitt W.G., and Pitina L. Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: Effect of micelle structure and ultrasound on the intracellular drug uptake. J Controlled Release 1999, 58, 153-162.
20. Benahmed A., Ranger M., and Leroux J-C. Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L- lactide). Pharm. Res. 2001, 18, 323-328.
21. Calderera F., Hruska Z., Hurtrez G., Lerch J-P., Nugay T., and Riess G. Investigation of olystyrene-poly(etirylene oxide)block copolymer micelle formation in organic and aqueous solutions by nonradiative energy transfer experiments. Macromolecules 1994, 27, 1210-1215.
22. Wang Y., Kausch C. M., Chun M., Quirk R. P., and Mattice W. L. Exchange of chains between micelles of labeled polystyrene-block-poly(oxyethylene) as monitored by nonradiative singlet energy transfer. Macromolecules 1995, 28, 904-11.
23. Wilhelm M., Zhao C-L., Wang Y., Xu R. and Winnik R. A. Poly(styreneethylene oxide) block copolymer micelle formation in water: A fluorescence probe study. Macromolecules 1991, 24, 1033-40.
24. Desjardins A. and Eisenberg A. Colloidal properties of block ionomers. I. Characterization of reverse micelles of styrene-b-metal methacrylate diblocks by size-exclusion chromatography. Macromolecules 1991, 24, 5779-90.
25. Hoes C. J. T., Potman W., van Heeswijk W. A. R., Mud J., de Grooth B. G., Grave J., and Feijen J. Optimization of macromolecular prodrugs of the antitumor antibiotic adriamycin. J Controlled Release 1985, 2, 205-213.
26. Duncan R., Kopeckova-Rejmanova P, Strohalm J., Hume I., Cable H.C., Pohl J., Lloyd J. B., and Kopeèek J. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers I. Evaluation of daunomycin and puromycin conjugates in vitro. Br. J Cancer 1987, 55, 165-174.
27. Endo N., Umemoto N., Kato Y., Takeda Y., and Hare T. A novel covalent modification of antibodies at their amino groups with retention of antigenbinding activity. J. Immunol. Methods 1987, 104, 253-258.
28. Zunino F., Pratesi G., and Micheloni A. Poly(carboxylic acid) polymers as carriers for anthracyclines. J Controlled Release 1989, 10, 65-73.
29. Hirano T., Ohashi S., Morimoto S., Tsukada K., Kobayashi T., and Tsukagoshi S. Synthesis of antitumor-active conjugates of adriamycin or daunomycin with the copolymer of divinyl ether maleic anhydride. Makromol. Chem. 1986, 187, 2815-2824.
30. Tsukada Y., Kato Y., Umemoto N., Takeda Y., Hara T., and Hirai H. An anti-a-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier. J. Natl. Cancer Inst. 1984, 73, 721-729.
31. Yokoyama M., Kwon G. S., Okano T., Sakurai Y., Seto T., and Kataoka K. Preparation of micelle-forming polymer-drug conjugates. Bioconjugate Chemistry 1992, 3, 295-301.
32. Kabanov A.V. and Alakhov, V.Y. Micelles of amphiphilic block copolymers as vehicles for drug delivery. In Alexandridis P. and Lindmay B. eds. Amplhiphilic Block Copolymers: Self Assembly and Applications, Elsevier, Netherlands, 1997, pp. 1-31
33. Kwon G.S., Naito M., Kataoka K., Yokoyama M., Sakurai Y., and Okano T. Block copolymer micelles as vehicles for hydrophobic drugs. Colloids and Surfaces, B: Biointerfaces 1994, 2, 429-434.
34. Yokoyama M., Okano T., Sakurai Y., and Kataoka K. Improved synthesis of adriamycin-conjugated polyethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Controlled Release 1994, 32, 269-277.
35. Kwon G.S., Naito M., Yokoyama M., Okano T., Sakurai Y., and Kataoka K., Physical entrapment of adriamycin in AB block copolymer micelles, Pharm. Res. 1995, 12, 192-195.
36. Yokoyama M., Fukushima S., Uehara R., Okamoto K., Kataoka K., Sakurai Y., and Okano T. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Controlled Release 1998, 50, 79-92.
37. Yokoyama M., Okano T., Sakurai Y., Fukushima S., Okamoto K., and Kataoka K. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J Drug Targeting 1999, 7, 171-186
38. Yokoyama M., Satoh A., Sakurai Y., Okano T., Matsumura Y., Kakizoe T., Kataoka K. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Controlled Release 1998, 55, 219-229.
39. Matsumura Y., Yokoyama M., Kataoka K., Okano T., Sakurai Y., Kawaguchi T., and Kakizoe T. Reduction of the adverse effects of an antitumor agent, KRN 5500 by incorporation of the drug into polymeric micelles. Jap J Cancer Research 1999, 90, 122-128.
40. Mizumura Y., Matsumura Y., Yokoyama M., Okano T., Kawaguchi T., Moriyasu F., and Kakizoe T. Incorporation of the anticancer agent KRN 5500 into polymeric micelles diminishes the pulmonary toxicity. Jap J Cancer Research 2002, 93, 1237-1243.
41. Nishiyama N., Yokoyama M., Aoyagi T., Okano T., Sakurai Y., and Kataoka K. Preparation and characterization of self-assembled polymermetal complex micelle from cis-dichlorodiammineplatinum (II) and Polyethylene glycol)-poly(aspartic acid) block copolymer in an aqueous medium. Langmuir 1999, 15, 377-383.
42. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., Nishio K., Matsumura Y., and Kataoka K. Novel Cisplatin-Incorporated Polymeric Micelles Can Eradicate Solid Tumors in Mice, Cancer Res 2003, 63, 8977-8983.
43. Zhang X., Burt H.M., von Hoff D., Dexter D., Mangold G., Degen D., Oktaba A.M., and Hunter W.L. An investigation of the antitumor activity and biodistributiion ofg polymeric micllear pactitaxel, Cancer Chemether. Pharmacol. 1997, 40, 81-81.
44. Hamaguchi T., Matsumura Y., Suzuki M., Shimizu K., Goda R., Nakamura I., Nakatomi I., Yokoyama M., Kataoka, and Kakizoe T. NK105, a paclitaxel- incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br. J. Cancer, in press.
45. Li Y. and Kwon G.S. Methotrexate ester of polyethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part 1: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm. Res. 2000, 157, 607-611.